(STRV) EA Series Trust - Ratings and Ratios
Exchange-Traded Fund, Index Replication, Equity Securities
| Risk via 10d forecast | |
|---|---|
| Volatility | 17.6% |
| Value at Risk 5%th | 30.4% |
| Relative Tail Risk | 5.08% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.48 |
| Alpha | 0.67 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.423 |
| Beta | 0.966 |
| Beta Downside | 0.956 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.99% |
| Mean DD | 2.28% |
| Median DD | 1.15% |
Description: STRV EA Series Trust November 18, 2025
The STRV ETF seeks to track its benchmark index by allocating virtually all of its net assets-minus securities-lending collateral-into the index’s constituent stocks. The Sub-Adviser projects a pre-fee, pre-expense correlation of at least 95% with the index, indicating tight tracking performance.
Key data points (as of the latest filing) include an expense ratio of 0.10%, total assets under management of roughly $1.2 billion, and a top-10 holding concentration of about 30%, led by large-cap names such as Apple, Microsoft, and Johnson & Johnson. The fund’s sector tilt leans heavily toward technology (≈35%) and consumer discretionary (≈20%), making it sensitive to U.S. consumer spending trends and Federal Reserve interest-rate policy, which influence earnings growth for large-blend equities.
If you’re looking for a deeper, data-driven analysis of STRV’s risk-adjusted returns and factor exposures, you may find it useful to explore ValueRay for additional quantitative insights.
STRV ETF Overview
| Market Cap in USD | 1,009m |
| Category | Large Blend |
| TER | 0.05% |
| IPO / Inception | 2022-09-14 |
| Return 12m vs S&P 500 | 0.30% |
| Analyst Rating | - |
STRV Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 1.08% |
| Yield on Cost 5y | 1.91% |
| Yield CAGR 5y | 118.07% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
STRV Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 19.98% |
| CAGR/Max DD Calmar Ratio | 1.05 |
| CAGR/Mean DD Pain Ratio | 8.77 |
| Current Volume | 85k |
| Average Volume | 72.5k |
What is the price of STRV shares?
Over the past week, the price has changed by -2.96%, over one month by -2.87%, over three months by +2.63% and over the past year by +12.18%.
Is STRV a buy, sell or hold?
What are the forecasts/targets for the STRV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 48.2 | 14.1% |
STRV Fundamental Data Overview November 11, 2025
Beta = 1.0
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.01b USD (1.01b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.01b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.01b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.57% (E(1.01b)/V(1.01b) * Re(9.57%) + (debt-free company))
Discount Rate = 9.57% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for STRV ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle